Last reviewed · How we verify
NCT06945302
The Effect of Inulin Supplementation in Individuals With IBS-C
NA trial testing Intervention Group in Inulin in 34 participants. Completed in 1 April 2023.
3 January 2022
Quick facts
| Lead sponsor | Mardin Artuklu University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 3 November 2021 |
| Primary completion | 3 January 2022 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Intervention Group — full drug profile →
- Control group (placebo)
Conditions studied
- Inulin — all drugs for Inulin →
- IBS (Irritable Bowel Syndrome) — all drugs for IBS (Irritable Bowel Syndrome) →
- Nutritional Status — all drugs for Nutritional Status →
- Anthropometric Measurement — all drugs for Anthropometric Measurement →
Sponsor
Mardin Artuklu University
Who can join
Adults 19 to 65, any sex, with Inulin or IBS (Irritable Bowel Syndrome). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: This study aimed to evaluate the effects of inulin supplementation on nutritional intake, anthropometric parameters, and bowel symptoms in individuals diagnosed with IBS-C. Method: This was a randomised, single-blind, placebo-controlled clinical trial. Participants were randomly allocated into intervention (inulin) and control (placebo) groups for 8 weeks. Assessments included dietary intake, anthropometric measurements, and IBS symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06945302
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intervention Group
Trials testing the same drug.
- NCT07482033 — The Impact of Training on Self-Efficacy, Symptom Level, and Activities of Daily Living · NA · not yet recruiting
- NCT07485400 — Aerobic Interval vs Continuous Training on Heart Rate-Power Decoupling in Ischemic Heart Disease · NA · not yet recruiting
- NCT07298018 — A Pilot Study of RISE for Nurse Managers Retreat · NA · recruiting
- NCT07344285 — A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD · NA · not yet recruiting
- NCT07306221 — Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstructi · NA · recruiting
Other Mardin Artuklu University trials
Trials by the same sponsor.
- NCT07522021 — Daytime vs Evening Rehabilitation in Lumbar Disc Herniation Patients at High Risk for Obstructive Sleep Apnea · NA · not yet recruiting
- NCT07465874 — Validity and Reliability of the 6-Minute Pegboard and Ring Test (6PBRT) in Adults With Obstructive Sleep Apnea Syndrome · not yet recruiting
- NCT07238205 — Mixed Reality Training for Teaching Cervical Effacement and Dilation · NA · recruiting
- NCT07169058 — Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea · NA · enrolling by invitation
- NCT07049640 — Acupressure and Cold Application on Pain, Anxiety, Comfort, and Hemodynamic Parameters · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06945302 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mardin Artuklu University
- Last refreshed: 25 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06945302.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing